Esperion Reports Second Quarter 2025 Financial Results and Provides Business Update

– Q2 2025 Total Revenue Grew 12% Y/Y to $82.4 Million –

– Q2 2025 U.S. Net Product Revenue Grew 42% Y/Y to $40.3 Million –

– Total Retail Prescription Equivalents Increased 10% from First Quarter –

Read more at globenewswire.com